chr11-587385-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001286581.2(PHRF1):c.341C>T(p.Ala114Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,613,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A114T) has been classified as Likely benign.
Frequency
Consequence
NM_001286581.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHRF1 | NM_001286581.2 | c.341C>T | p.Ala114Val | missense_variant | 4/18 | ENST00000264555.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHRF1 | ENST00000264555.10 | c.341C>T | p.Ala114Val | missense_variant | 4/18 | 1 | NM_001286581.2 | P5 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000762 AC: 19AN: 249224Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135222
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461542Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727034
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.341C>T (p.A114V) alteration is located in exon 4 (coding exon 3) of the PHRF1 gene. This alteration results from a C to T substitution at nucleotide position 341, causing the alanine (A) at amino acid position 114 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at